MAO-B-IN-2 is primarily utilized in research settings to study the inhibition of monoamine oxidase B (MAO-B), an enzyme involved in the breakdown of neurotransmitters like dopamine. Its application is significant in the development of potential treatments for neurodegenerative disorders, particularly Parkinson’s disease, where MAO-B inhibition can help preserve dopamine levels in the brain. Additionally, it serves as a tool compound in pharmacological studies to explore the role of MAO-B in aging, oxidative stress, and other neurological conditions. Researchers also use MAO-B-IN-2 to investigate its potential neuroprotective effects and its impact on mood-related disorders.